2015 IHV Annual Meeting, 27-30 September Baltimore

The 17th Annual Meeting of the Institute of Human Virology - Baltimore has been again a relevant meeting on HIV/AIDS and the related opportunistic cancers driven by pathogens. Moreover, for the first time a short section has been dedicated also to the ebola virus research and the recent outbreak in West Africa

The relevance of the Meeting
The IHV Annual meeting represents the continuation of the Gallo’s laboratory annual meeting, an event that for almost 30 years has been crucial for HIV/AIDS research, and in general for the biomedicBobal science. It is sufficient to read science magazine articles on such event to get the flavor and the excitement: Robert Gallo’s “lab meeting” a mecca for AIDS researchers [Science, September 9, 1988]; Gallo’s Meeting: A Scientific ‘Folk Festival’ [The Scientist, November 14, 1994].
….. Gallo’s meeting has become something of a phenomenon–a small lab meeting turned international event. In a scientific arena marked by competition and conflict, much of it centering on Gallo himself, this wide-ranging gathering is testimony to the fact that, despite the competition, AIDS research is a shared enterprise ……
… “Gallo’s meeting has juice, that’s what it’s got,” declares Cecil H. Fox, an experimental pathologist, biochemist, and 20-year NIH veteran who is now president of Molecular Histology Laboratories Inc., Gaithersburg, Md. “That is, there’s a lot of interpersonal contact, there are colorful people that go to it, there are discussions, disagreements, and, frequently, hard feelings and good feelings that come out of it. It’s what scientific meetings are supposed to be about. It’s not a group of wooden people flying in on an airplane, getting off the plane, coming to the hotel or whatever it is, delivering a talk that they’ve delivered six times in the previous two months, getting back on the plane, and leaving.” …..
The meeting still represents the sensory experience Fox described in 1994, going into this [meeting] chamber, this darkened chamber, and you were sensorily deprived. You sat there, and you could see the podium and the lights on the podium and the slides, and you didn’t try to pay attention. But you emerged, mole-like, six or seven days later with a reordered understanding of the state of science associated with lentiviruses. It was an osmotic learning experience.”

Besides science few more events have taken place: The William Blattner retirement celebration and the IHV Lifetime Achievement Awards.

William Blattner retirement event
Bill retirement (which should officially take place next January) has been celebrated by all participants for his scientific achievements along with socio-medical involvement in developing countries, particularly in Nigeria.  The latter has been acknowledged in the  documentary movie produced by the Media and Communication Center at IHV-Nigeria under the directorship of Dr Alash’le G. Abimiku: Blattner’s Valediction.


IHV Lifetime Achievement Awards to Harald zur Hausen and Anthony Fauci



Harald zur Hausen, the 2008 Nobel Laureate, received the Lifetime Achievement Award, following his afternoon  2015 Reinhard Kurth Memorial Lecture, mainly focused on his current interest on Bovine Milk & Meat Factors (BMMF) role in human cancers.


Anthony Fauci received the Lifetime Achievement Award for Scientific Contributions & Public Service in his 31 years leading involvement in AIDS research and treatment as NIAID director.



Staffan Hildebrabd documentary
The evening included a documentary from Staffan Hildebrand, who has been filming the HIV/AIDS epidemic since 1986, and is the founder and producer of the Face of AIDS film archive housed at the prestigious Karolinska Institutet in Sweden [https://kib.ki.se/en/faceofaids].

Conclusive remarks
In conclusion the 17th Annual Meeting of the Institute of Human Virology (IHV) has continued the tradition of engaging world science leaders to share cutting edge research advances, focusing on an HIV cure, pathogenesis, basic and translational vaccine research, as well as collective lessons from recent advances in cancer immunology.

Franco Buonaguro

Dr Buonaguro is the Editor-in-Chief of Infectious Agents and Cancer. He is currently the Director of Molecular Biology and Viral Oncology Unit, in the Department of Experimental Oncology at the Natl Cancer Institute “Fondazione Pascale”, Naples - Italy.

View the latest posts on the On Biology homepage